CC, S., TK, H., CS, S., & YC, S. (2025). Risk Factors and Multiple Interaction Effects for Hyperammonemia in Patients Receiving Valproic Acid. Fundamental & clinical pharmacology, 39(4), e70030. https://doi.org/10.1111/fcp.70030
Chicago Style (17th ed.) CitationCC, Su, Huang TK, Shih CS, and Su YC. "Risk Factors and Multiple Interaction Effects for Hyperammonemia in Patients Receiving Valproic Acid." Fundamental & Clinical Pharmacology 39, no. 4 (2025): e70030. https://doi.org/10.1111/fcp.70030.
MLA (9th ed.) CitationCC, Su, et al. "Risk Factors and Multiple Interaction Effects for Hyperammonemia in Patients Receiving Valproic Acid." Fundamental & Clinical Pharmacology, vol. 39, no. 4, 2025, p. e70030, https://doi.org/10.1111/fcp.70030.
Warning: These citations may not always be 100% accurate.